Production (Stage)
CareDx, Inc
CDNA
$16.95
-$0.16-0.94%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 25.92% | 19.07% | 5.26% | -3.95% | -13.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.92% | 19.07% | 5.26% | -3.95% | -13.93% |
| Cost of Revenue | 9.95% | 7.48% | 1.12% | -5.12% | -8.38% |
| Gross Profit | 35.33% | 25.70% | 7.55% | -3.31% | -16.89% |
| SG&A Expenses | 2.62% | 4.05% | -4.44% | 0.45% | 0.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.01% | 1.64% | -5.26% | -4.93% | -6.13% |
| Operating Income | 58.56% | 45.29% | 37.05% | 8.39% | -24.10% |
| Income Before Tax | 131.80% | 126.10% | -62.10% | -95.08% | -132.53% |
| Income Tax Expenses | 783.33% | 119.86% | 104.03% | -95.16% | -112.82% |
| Earnings from Continuing Operations | 131.57% | 125.92% | -62.17% | -93.95% | -130.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 131.57% | 125.92% | -62.17% | -93.95% | -130.97% |
| EBIT | 58.56% | 45.29% | 37.05% | 8.39% | -24.10% |
| EBITDA | 67.52% | 52.33% | 43.77% | 11.70% | -24.97% |
| EPS Basic | 131.00% | 124.94% | -64.29% | -95.30% | -131.47% |
| Normalized Basic EPS | 65.10% | 48.25% | 45.19% | 17.48% | -12.91% |
| EPS Diluted | 128.17% | 122.23% | -63.76% | -94.17% | -129.44% |
| Normalized Diluted EPS | 66.45% | 49.57% | 45.19% | 17.48% | -12.91% |
| Average Basic Shares Outstanding | 0.72% | -1.85% | -2.33% | -1.42% | -0.37% |
| Average Diluted Shares Outstanding | 2.57% | -0.02% | -2.33% | -1.42% | -0.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |